4SC to Present at Two Upcoming Investor Conferences

News Apr 17, 2012

4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, will be presenting at two investor conferences this week.

Dr Ulrich Dauer, Chief Executive Officer of 4SC AG, will give a company presentation at the Future Leaders in the Biotech Industry conference, which will be held on 20 April 2012 in New York City, USA.

The presentation of 4SC will begin at 9.00am (ET).

Enno Spillner, Chief Financial Officer of 4SC AG, will give a company presentation at the 3rd FCF Family-to-Family Day, an investor conference exclusively for family offices and HNIs (High Net Worth Individuals) on 19 April 2012 in Munich.

The presentation of 4SC will begin at 3.15pm (CET).

Therapeutic Approach to Tackle African Sleeping Sickness

News

A small inhibitor molecule inhibits parasitic enzyme. This novel concept could also be employed in the future rational design of drugs for the treatment of other diseases.

Compound Could Help Treat Ovarian Cancer

News

Scientists from the University of Sheffield have discovered a compound that could be more effective in treating certain cancers than standard chemotherapy.

Reversing Memory Loss Linked to Depression and Aging

News

New therapeutic molecules developed at Toronto’s Centre for Addiction and Mental Health (CAMH) show promise in reversing the memory loss linked to depression and aging.

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free